Stories
2023 Insights event brings pharma and Prime/MRx leaders together
More than 300 pharma representatives attended this annual gathering to learn more about what Prime/MRx has to offer
November 2, 2023The Insights event took place in Orange County, CA where Prime/MRx trade team members and executives shared company updates and networked with key industry representatives and pharmaceutical manufacturers.
On the agenda
Topic-focused presentations:
- A government affairs update
- The latest information on oncology programs, including IntegratedRx®
- Health outcomes case studies on value-based contracting, GLP-1 and HighTouchRx®
- A specialty drug management session
Informative panels: Two panels gave the pharma audience a chance to ask the Prime/MRx team questions on their minds.
- The first as a fireside chat featuring pharmacy benefit management leadership addressing topics including the Prime/MRx integration, corporate strategy and future vision.
- The second panel included a rotating cast of trade team members representing all lines of business addressing how Prime/MRx and pharma can best work together to maximize patient outcomes.
Networking: The event opened with an evening reception before the formal program began. The reception included a “speed networking” session to close out Day 1 aimed at mixing up attendees and staff in a casual, get-to-know-you format.
“I have received incredible feedback from our attendees on the success of this year’s Insights event. Everyone enjoyed the location, the content and the networking. We look forward to continuing to advance our relationship with pharma through this event and other connections throughout the year,” said Emily Colaizy, assistant vice president, pharmaceutical trade relations.
Related news
Stories
July 22, 2024
Introducing the latest issue of our medical and pharmacy benefit management report
The summer 2024 issue of the Magellan Rx Report provides insights on the industry’s most groundbreaking managed care solutions in some of the most complex areas of health care
Stories
July 18, 2024
Specialty drug trend forecasted to drop for employer groups, clinical experts say
Introduction of Humira® and Stelara® biosimilars contribute to continued decline in the autoimmune – anti-inflammatory trend
Stories
July 16, 2024
Prime/Magellan Rx earns top score on the Disability Equality Index
For the second consecutive year, Prime Therapeutics/Magellan Rx Management received a score of 100 on the Disability Equality Index®, which benchmarks disability workplace inclusion